CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques

A major barrier to human immunodeficiency virus (HIV) cure is the existence of viral reservoirs that lead to viral rebound following discontinuation of antiretroviral therapy (ART). We postulate that enhancing cytotoxic T lymphocytes (CTL) targeting conserved envelope (Env) regions can eliminate HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Jin, Liang, Hua, Ji, Xiaolin, Wang, Shuo, Xue, Jing, Li, Dan, Peng, Hong, Qin, Chuan, Yee, Cassian, Shao, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529452/
https://www.ncbi.nlm.nih.gov/pubmed/31113957
http://dx.doi.org/10.1038/s41467-019-09725-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529452/
https://www.ncbi.nlm.nih.gov/pubmed/31113957
http://dx.doi.org/10.1038/s41467-019-09725-6

Ejemplares similares